HSBC raises Regeneron Pharma price target to $920 from $800
HSBC maintained Regeneron Pharma at Buy and raised its price target to $920.00 per share from $800.00, according to TradingView News ratings actions reported by Benzinga.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.